-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Management Of Adult BCR/ABL1+ Acute Lymphocytic Leukemia

Program: Education Program
Session: Novel Approaches to Acute Lymphoblastic Leukemia
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Tangerine 3 (WF3-4), Level 2 (Orange County Convention Center)
Saturday, December 5, 2015, 4:00 PM-5:30 PM
Tangerine 2 (WF2), Level 2 (Orange County Convention Center)

Robin Foŕ, MD

Department of Biomedical Sciences and Hematology, Sapienza University of Rome, Rome, Italy

Disclosures: Foŕ: Genentech: Membership on an entity’s Board of Directors or advisory committees , Speakers Bureau ; Gilead: Speakers Bureau ; Janssen: Membership on an entity’s Board of Directors or advisory committees , Speakers Bureau ; Novartis: Speakers Bureau ; BMS: Speakers Bureau ; Sandoz: Speakers Bureau ; Celgene: Speakers Bureau ; Ariad: Membership on an entity’s Board of Directors or advisory committees ; Amgen: Membership on an entity’s Board of Directors or advisory committees ; Roche: Membership on an entity’s Board of Directors or advisory committees , Speakers Bureau .

See more of: Novel Approaches to Acute Lymphoblastic Leukemia
See more of: Education Program
<< Previous Presentation | Next Presentation >>